NCT05635331View on ClinicalTrials.gov

Real-world Dapagliflozin Experience in Patients With Heart Failure in Greece

CompletedOBSERVATIONAL
Enrollment

257

Participants

Timeline

Start Date

December 28, 2022

Primary Completion Date

December 3, 2024

Study Completion Date

December 3, 2024

Conditions
Heart Failure
Trial Locations (16)

11526

Research Site, Athens

11527

Research Site, Athens

11528

Research Site, Athens

12462

Research Site, Athens

14233

Research Site, Athens

17674

Research Site, Athens

26504

Research Site, Pátrai

45445

Research Site, Ioannina

45500

Research Site, Ioannina

54636

Research Site, Thessaloniki

54642

Research Site, Thessaloniki

56429

Research Site, Thessaloniki

57010

Research Site, Thessaloniki

68100

Research Site, Alexandroupoli

71409

Research Site, Heraklion

73300

Research Site, Chania

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY